Bringing Advanced Therapy Medicinal Products (ATMPs) for Parkinson's Disease to the Clinic: The Investigator's Perspective. (2021)
Attributed to:
The Pluripotent Stem Cells and Engineered Cell (PSEC) Hub
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3233/jpd-212563
PubMed Identifier: 33814466
Publication URI: http://europepmc.org/abstract/MED/33814466
Type: Journal Article/Review
Volume: 11
Parent Publication: Journal of Parkinson's disease
Issue: s2
ISSN: 1877-7171